- Location
pharmaceutical products
"-
US-Based Sagent Pharmaceuticals Has Introduced Propofol Injectable Emulsion USP 1%
Nov 20, 2013US-based Sagent Pharmaceuticals has introduced propofol injectable emulsion USP 1%, in two single-dose, single-patient vial presentations of 20mL and 100mL. The company said that a 50mL single-dose, single-patient vial presentation will ...
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 14, 2013US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
-
Vitamin C Is Used Extensively in Cosmetic and Pharmaceutical Products
Nov 12, 2013Australian botanical extract manufacturer, Native Extracts announces what they describe as a ‘world breakthrough’ in that their advanced ‘cellular’ extraction process stabilises vitamin C for extended periods in an ...
Tags: Vitamin C
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 8, 2013US-based Sagent Pharmaceuticals (SGNT) has introduced an antineoplastic agent 'Carboplatin Injection' in four preservative-free vial presentations. The injection is indicated for the initial treatment of advanced ovarian carcinoma in ...
-
Antares Pharma Has Received a US Patent,Entitled 'Prefilled Syringe Jet Injector'
Oct 29, 2013Antares Pharma, a provider of self-injection drug delivery technology, has received a US Patent, entitled 'Prefilled Syringe Jet Injector', which will help in protecting its auto injector technology and product pipeline including the VIBEX ...
-
Innocore Signed an Agreement with Allergan to Develop New Drugs for Ophthalmic Diseases
Oct 24, 2013Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for ophthalmic diseases. The deal will see the ...
Tags: injectable drug, Innocore
-
Vitamin C Is Notorious for Being Highly Unstable and Dissipates Rapidly in Solutions
Oct 17, 2013Australian botanical extract manufacturer, Native Extracts announces what they describe as a 'world breakthrough' in that their advanced 'cellular' extraction process stabilises vitamin C for extended periods in an aqueous matrix, ...
Tags: Light Industry, Daily Use, skin care, vitamin C
-
Mystic Pharmaceuticals Has Received Notices of Allowance for New Patent Applications
Oct 8, 2013Mystic Pharmaceuticals has received notices of allowance from the China Patent Office and the Japan Patent Office for its 'Deep Draw Container Forming Method' and 'Combination Unit Dose Dispensing Container' patent applications ...
Tags: Drug Delivery Platforms, Medicine
-
US-Based Mystic Pharmaceuticals Has Secured Two Notices of Allowance
Sep 19, 2013US-based Mystic Pharmaceuticals has secured two Notices of Allowance from the US Patent Office for its Unit Dose Drug Delivery Platform and Piercing Device for Drug Delivery Systems patent applications. According to the company, the new ...
-
Sales of Cross-Flow Membrane Will Exceed US$10.4 Billion in 2014
Sep 18, 2013Sales of cross-flow membrane equipment and replacement modules will exceed US$10.4 billion in 2014. The reverse osmosis (RO) segment will comprise more than 50% of the total. This is the latest finding in the continually updated RO, UF, ...
Tags: Cross-Flow Membrane
-
SK Capital Is Expected to Close The Acquisition of The Textile Chemicals
Sep 18, 2013SK Capital, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, is expected to close the acquisition of the Textile Chemicals, Paper Specialties and Emulsions businesses from ...
Tags: specialty materials, Textile
-
MHA and CoverMyMeds Have Joined Hands to Provide a Co-Branded Solution
Sep 17, 2013Managed Health Care Associates (MHA) and CoverMyMeds have joined hands to provide a co-branded solution to MHA's pharmacy members for facilitating a more efficient process for completing and submitting drug prior authorizations (PA). ...
Tags: MHA Partners, CoverMyMeds
-
Cubist Pharmaceuticals Has Completed The Acquisition of Trius Therapeutics
Sep 13, 2013US-based biopharmaceutical firm Cubist Pharmaceuticals has completed the acquisition of Trius Therapeutics, which is focused on the development of antibiotics, for about $704m. The acquisition of Trius brings to Cubist a late-stage ...
-
Sales of Cross-Flow Membrane Will Exceed $10.4 Billion in 2014
Sep 12, 2013Sales of cross-flow membrane equipment and replacement modules will exceed $10.4 billion in 2014. The reverse osmosis (RO) segment will comprise more than 50% of the total. This is the latest finding in the continually updated RO, UF, MF ...
-
Vita Health Has Voluntarily Recalled Various Health Products
Sep 10, 2013Pharmaceutical products manufacturer Vita Health has voluntarily recalled various health products from the Canadian market due to labeling issues. The labels suggest that the packages are child resistant when they are not, or are missing ...
Related Products
-
Reduced L-Glutathione Pharmaceutical Grade Skin Care
-
Customized Corrugated Cosmetic Electronic Products Color Box Coated Paper Pharmaceutical Packaging Box
-
Skin Rejuvenation L-Glutathione Reduced Formula
-
High-Density Glutathione for Skin Brightening Effects
-
High-Density Glutathione for Skin Glow
-
Top-Quality L-Glutathione for Skin Care Routine
